Article summary
The Department of Health and Social Care (DHSC) has announced the launch of a new national initiative named ACCORD, which will accelerate the development of coronavirus (COVID-19) treatments by reducing the time taken to set up clinical studies for new therapies from months to weeks. Six potential drugs will enter the initiative, with the first entering phase two studies where the effectiveness of the drug and any side effects in patients are assessed.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial